Search Results - SharonR Lewin

Refine Results
  1. 1
    HIV Infection and TLR Signalling in the Liver

    HIV Infection and TLR Signalling in the Liver by Megan Crane, Kumar Visvanathan, Sharon R. Lewin

    Published 2012-01-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    The RNA-Binding Proteins SRP14 and HMGB3 Control HIV-1 Tat mRNA Processing and Translation During HIV-1 Latency

    The RNA-Binding Proteins SRP14 and HMGB3 Control HIV-1 Tat mRNA Processing and Translation During HIV-1 Latency by Georges Khoury, Michelle Y. Lee, Sri H. Ramarathinam, James McMahon, Anthony W. Purcell, Secondo Sonza, Sharon R. Lewin, Sharon R. Lewin, Sharon R. Lewin, Damian F. J. Purcell

    Published 2021-06-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    The end of HIV: Still a very long way to go, but progress continues.

    The end of HIV: Still a very long way to go, but progress continues. by Steven G Deeks, Sharon R Lewin, Linda-Gail Bekker

    Published 2017-11-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Therapeutics for COVID-19: established and in development

    Therapeutics for COVID-19: established and in development by Jennifer Audsley, Sharon R Lewin, Joe Sasadeusz, Kasha P Singh

    Published 2020-01-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Immune checkpoint blockade in HIV

    Immune checkpoint blockade in HIV by Celine Gubser, Chris Chiu, Sharon R. Lewin, Thomas A. Rasmussen

    Published 2022-02-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Modeling the Effects of Vorinostat In Vivo Reveals both Transient and Delayed HIV Transcriptional Activation and Minimal Killing of Latently Infected Cells.

    Modeling the Effects of Vorinostat In Vivo Reveals both Transient and Delayed HIV Transcriptional Activation and Minimal Killing of Latently Infected Cells. by Ruian Ke, Sharon R Lewin, Julian H Elliott, Alan S Perelson

    Published 2015-10-01
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Soluble immune checkpoints as correlates for HIV persistence and T cell function in people with HIV on antiretroviral therapy

    Soluble immune checkpoints as correlates for HIV persistence and T cell function in people with HIV on antiretroviral therapy by Chris Y. Chiu, Maya D. Schou, James H. McMahon, Steven G. Deeks, Rémi Fromentin, Rémi Fromentin, Nicolas Chomont, Nicolas Chomont, Michelle N. Wykes, Thomas A. Rasmussen, Thomas A. Rasmussen, Sharon R. Lewin, Sharon R. Lewin, Sharon R. Lewin

    Published 2023-03-01
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    Unequal distribution of genetically-intact HIV-1 proviruses in cells expressing the immune checkpoint markers PD-1 and/or CTLA-4

    Unequal distribution of genetically-intact HIV-1 proviruses in cells expressing the immune checkpoint markers PD-1 and/or CTLA-4 by Katie Fisher, Katie Fisher, Timothy E. Schlub, Zoe Boyer, Zoe Boyer, Thomas A. Rasmussen, Thomas A. Rasmussen, Ajantha Rhodes, Rebecca Hoh, Frederick M. Hecht, Steven G. Deeks, Sharon R. Lewin, Sharon R. Lewin, Sharon R. Lewin, Sarah Palmer, Sarah Palmer

    Published 2023-01-01
    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    Detection of Chimeric Cellular: HIV mRNAs Generated Through Aberrant Splicing in HIV-1 Latently Infected Resting CD4+ T Cells

    Detection of Chimeric Cellular: HIV mRNAs Generated Through Aberrant Splicing in HIV-1 Latently Infected Resting CD4+ T Cells by Michelle Y-H Lee, Georges Khoury, Moshe Olshansky, Secondo Sonza, Glen P. Carter, Glen P. Carter, James McMahon, Timothy P. Stinear, Timothy P. Stinear, Stephen J. Turner, Sharon R. Lewin, Sharon R. Lewin, Sharon R. Lewin, Damian F. J. Purcell

    Published 2022-04-01
    Get full text
    Article
    Save to List
    Saved in:
  10. 10
    Circulating heat shock protein 60 levels are elevated in HIV patients and are reduced by anti-retroviral therapy.

    Circulating heat shock protein 60 levels are elevated in HIV patients and are reduced by anti-retroviral therapy. by Itaru Anraku, Reena Rajasuriar, Caroline Dobbin, Richard Brown, Sharon R Lewin, Andreas Suhrbier

    Published 2012-01-01
    Get full text
    Article
    Save to List
    Saved in:
  11. 11
    Design and analysis considerations for early phase clinical trials in hepatitis B (HBV) cure research: the ACTG A5394 study in persons with both HIV and HBV

    Design and analysis considerations for early phase clinical trials in hepatitis B (HBV) cure research: the ACTG A5394 study in persons with both HIV and HBV by Minhee Kang, Jennifer C. Price, Marion G. Peters, Sharon R. Lewin, Mark Sulkowski

    Published 2023-09-01
    Get full text
    Article
    Save to List
    Saved in:
  12. 12
    Decreased NK Cell FcRgamma in HIV-1 infected individuals receiving combination antiretroviral therapy: a cross sectional study.

    Decreased NK Cell FcRgamma in HIV-1 infected individuals receiving combination antiretroviral therapy: a cross sectional study. by Edwin Leeansyah, Jingling Zhou, Geza Paukovics, Sharon R Lewin, Suzanne M Crowe, Anthony Jaworowski

    Published 2010-01-01
    Get full text
    Article
    Save to List
    Saved in:
  13. 13
    No difference in the rate of change in telomere length or telomerase activity in HIV-infected patients after three years of darunavir/ritonavir with and without nucleoside analogues in the MONET trial.

    No difference in the rate of change in telomere length or telomerase activity in HIV-infected patients after three years of darunavir/ritonavir with and without nucleoside analogue... by Ajantha Solomon, Surekha Tennakoon, Edwin Leeansyah, Jose Arribas, Andrew Hill, Yvon Van Delft, Christiane Moecklinghoff, Sharon R Lewin

    Published 2014-01-01
    Get full text
    Article
    Save to List
    Saved in:
  14. 14
    Interrupting antiretroviral therapy in HIV cure trials during COVID-19: Adaptation to low transmission settings

    Interrupting antiretroviral therapy in HIV cure trials during COVID-19: Adaptation to low transmission settings by Jillian SY. Lau, Thomas A. Rasmussen, Sharon R. Lewin, Adam Ehm, Cipriano Martinez, Craig Burnett, James H. McMahon

    Published 2021-03-01
    Get full text
    Article
    Save to List
    Saved in:
  15. 15
    Acceptability, motivation and the prospect of cure for people living with HIV and their healthcare providers in HIV cure-focused treatment interruption studies

    Acceptability, motivation and the prospect of cure for people living with HIV and their healthcare providers in HIV cure-focused treatment interruption studies by Jillian S. Y. Lau, Miranda Z. Smith, Brent Allan, Cipriano Martinez, Jennifer Power, Sharon R. Lewin, James H. McMahon

    Published 2020-11-01
    Get full text
    Article
    Save to List
    Saved in:
  16. 16
    Statistical analysis of single-copy assays when some observations are zero

    Statistical analysis of single-copy assays when some observations are zero by Peter Bacchetti, Ronald J. Bosch, Eileen P. Scully, Xutao Deng, Michael P. Busch, Steven G. Deeks, Sharon R. Lewin

    Published 2019-07-01
    Get full text
    Article
    Save to List
    Saved in:
  17. 17
    Clinical predictors of immune reconstitution following combination antiretroviral therapy in patients from the Australian HIV Observational Database.

    Clinical predictors of immune reconstitution following combination antiretroviral therapy in patients from the Australian HIV Observational Database. by Reena Rajasuriar, Maelenn Gouillou, Tim Spelman, Tim Read, Jennifer Hoy, Matthew Law, Paul U Cameron, Kathy Petoumenos, Sharon R Lewin

    Published 2011-01-01
    Get full text
    Article
    Save to List
    Saved in:
  18. 18
    Differential expression of CD163 on monocyte subsets in healthy and HIV-1 infected individuals.

    Differential expression of CD163 on monocyte subsets in healthy and HIV-1 infected individuals. by Emma Tippett, Wan-Jung Cheng, Clare Westhorpe, Paul U Cameron, Bruce J Brew, Sharon R Lewin, Anthony Jaworowski, Suzanne M Crowe

    Published 2011-01-01
    Get full text
    Article
    Save to List
    Saved in:
  19. 19
    Quantifying Adaptive and Innate Immune Responses in HIV-Infected Participants Using a Novel High Throughput Assay.

    Quantifying Adaptive and Innate Immune Responses in HIV-Infected Participants Using a Novel High Throughput Assay. by Michelle K Yong, Paul U Cameron, Tim Spelman, Julian H Elliott, Christopher K Fairley, Jeffrey Boyle, Misato Miyamasu, Sharon R Lewin

    Published 2016-01-01
    Get full text
    Article
    Save to List
    Saved in:
  20. 20
    The significance and expectations of HIV cure research among people living with HIV in Australia.

    The significance and expectations of HIV cure research among people living with HIV in Australia. by Jennifer Power, Gary W Dowsett, Andrew Westle, Joseph D Tucker, Sophie Hill, Jeremy Sugarman, Sharon R Lewin, Graham Brown, Jayne Lucke

    Published 2020-01-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: